Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 18.12M | € 42.05M | € 60.92M | € 47.60M | € 42.97M |
Total Assets | € 245.62M | € 275.14M | € 254.53M | € 228.10M | € 215.35M |
Total Debt | € 79.49M | € 69.21M | € 58.54M | € 59.82M | € 59.27M |
Net Debt | € 61.37M | € 27.15M | € -2.38M | € 12.22M | € 16.30M |
Total Liabilities | € 109.80M | € 102.27M | € 82.82M | € 91.50M | € 85.47M |
Stockholders Equity | € 130.46M | € 137.34M | € 135.47M | € 99.44M | € 94.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |